PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease

PLoS Pathogens

Volumn 12, Issue 3, 2016, Pages

  Ramos Sevillano, Elisa ^a,b,c   Urzainqui, Ana ^d   de Andrés, Belén ^c   González Tajuelo, Rafael ^d   Domenech, Mirian ^a,b   González Camacho, Fernando ^c   Sánchez Madrid, Francisco ^d   Brown, Jeremy S ^e   García, Ernesto ^a,b   Yuste, Jose ^b,c  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLYSIN; BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; P SELECTIN GLYCOPROTEIN LIGAND 1; TUMOR NECROSIS FACTOR ALPHA; MEMBRANE PROTEIN; N ACETYLMURAMOYLALANINE AMIDASE; P-SELECTIN LIGAND PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM COLONY; BLOODSTREAM INFECTION; BRONCHOALVEOLAR LAVAGE FLUID; CELL MIGRATION; CHRONIC INFLAMMATION; COLONY FORMING UNIT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE RESPONSE; INTERNALIZATION; LEUKOCYTE ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTION; ANIMAL; C57BL MOUSE; DISEASE MODEL; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; LEUKOCYTE; LUNG; METABOLISM; MICROBIOLOGY; NEUTROPHIL; PATHOLOGY; SEPSIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LEUKOCYTES; LUNG; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; NEUTROPHILS; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 84962407494     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005500     Document Type: Article

References (53)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009; 374: 893–902. doi: 10.1016/S0140-6736(09)61204-619748398.
2. O'Brien KL, Levine OS, Effectiveness of pneumococcal conjugate vaccine. Lancet. 2006; 368: 1469–70. doi: 10.1016/S0140-6736(06)69614-117071264.
3. van der Poll T, Opal SM, Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009; 374: 1543–56. doi: 10.1016/S0140-6736(09)61114-419880020.
4. Lanoue A, Clatworthy MR, Smith P, Green S, Townsend MJ, Jolin HE, et al. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J Exp Med. 2004; 200: 1383–93. doi: 10.1084/jem.2004079515583012.
5. Clatworthy MR, Smith KGC, FcγRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med. 2004; 199: 717–23. doi: 10.1084/jem.2003219714981111.
6. Arredouani M, Yang Z, Ning Y, Qin G, Soininen R, Tryggvason K, et al. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med. 2004; 200: 267–72. doi: 10.1084/jem.2004073115263032.
7. Ku C-L, von Bernuth H, Picard C, Zhang S-Y, Chang H-H, Yang K, et al. Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007; 204: 2407–22. doi: 10.1084/jem.2007062817893200.
8. Vicente-Manzanares M, Sánchez-Madrid F, Role of the cytoskeleton during leukocyte responses. Nat Rev Immunol. 2004; 4: 110–22. doi: 10.1038/nri126815040584.
9. Bullard DC, Kunkel EJ, Kubo H, Hicks MJ, Lorenzo I, Doyle NA, et al. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med. 1996; 183: 2329–36. doi: 10.1084/jem.183.5.23298642341.
10. Munoz FM, Hawkins EP, Bullard DC, Beaudet AL, Kaplan SL, Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin–deficient mice. J Clin Invest. 1997; 100: 2099–106. doi: 10.1172/JCI1197449329976.
11. McEver RP, Cummings RD, Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997; 100: 485–491. doi: 10.1172/JCI1195569239393.
12. Sako D, Chang XJ, Barone KM, Vachino G, White HM, Shaw G, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 1993; 75: 1179–86. doi 0092-8674(93)90327-M. 7505206.
13. Cossart P, Sansonetti PJ, Bacterial invasion: the paradigms of enteroinvasive pathogens. Science. 2004; 304: 242–8. doi: 10.1126/science.109012415073367.
14. Herron MJ, Nelson CM, Larson J, Snapp KR, Kansas GS, Goodman JL, Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science. 2000; 288: 1653–6. 10834846.
15. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H, Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009; 15: 794–7. doi: 10.1038/nm.196119543284.
16. Troese MJ, Carlyon JA, Anaplasma phagocytophilum dense-cored organisms mediate cellular adherence through recognition of human P-selectin glycoprotein ligand 1. Infect Immun. 2009; 77: 4018–27. doi: 10.1128/IAI.00527-0919596771.
17. Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol. 1997; 4: 415–22. 9220157.
18. Stuart LM, Ezekowitz RAB, Phagocytosis: elegant complexity. Immunity. 2005; 22: 539–50. doi: 10.1016/j.immuni.2005.05.00215894272.
19. Medzhitov R, Janeway CA, JrDecoding the patterns of self and nonself by the innate immune system. Science. 2002; 296: 298–300. doi: 10.1126/science.106888311951031.
20. Ramos-Sevillano E, Urzainqui A, Campuzano S, Moscoso M, González-Camacho F, Domenech M, et al. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response. Infect Immun. 2015; 83: 591–603. doi: 10.1128/IAI.02811-1425404032.
21. López R, García E, Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev. 2004; 28: 553–80. doi: 10.1016/j.femsre.2004.05.00215539074.
22. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS, The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun. 2010; 78: 704–15. doi: 10.1128/IAI.00881-0919948837.
23. Hyams C, Yuste J, Bax K, Camberlein E, Weiser JN, Brown JS, Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype. Infect Immun. 2010; 78: 716–25. doi: 10.1128/IAI.01056-0919948838.
24. Fenoll A, Granizo J-J, Giménez M-J, Yuste J, Aguilar L, Secular trends (1990–2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination. Vaccine. 2015; 33: 5691–9. doi: 10.1016/j.vaccine.2015.08.00926341563.
25. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER, Neutrophil kinetics in health and disease. Trends Immunol. 2010; 31: 318–24. doi: 10.1016/j.it.2010.05.00620620114.
26. Standish AJ, Weiser JN, Human neutrophils kill Streptococcus pneumoniae via serine proteases. J Immunol. 2009; 183: 2602–9. doi: 10.4049/jimmunol.090068819620298.
27. Underhill DM, Goodridge HS, Information processing during phagocytosis. Nat Rev Immunol. 2012; 12: 492–502. doi: 10.1038/nri324422699831.
28. Kadioglu A, De Filippo K, Bangert M, Fernandes VE, Richards L, Jones K, et al. The integrins Mac-1 and α4β1 perform crucial roles in neutrophil and T cell recruitment to lungs during Streptococcus pneumoniae infection. J Immunol. 2011; 186: 5907–15. doi: 10.4049/jimmunol.100153321460207.
29. Mizgerd JP, Meek BB, Kutkoski GJ, Bullard DC, Beaudet AL, Doerschuk CM, Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs. J Exp Med. 1996; 184: 639–45. doi: 10.1084/jem.184.2.6398760817.
30. Park IH, Geno KA, Yu J, Oliver MB, Kim K- H, Nahm MH, Genetic, biochemical, and serological characterization of a new pneumococcal serotype, 6H, and generation of a pneumococcal strain producing three different capsular repeat units. Clin Vaccine Immunol. 2015; 22: 313–8. doi: 10.1128/CVI.00647-1425589550.
31. Brueggemann AB, Pai R, Crook DW, Beall B, Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 2007; 3: e168. doi: 10.1371/journal.ppat.003016818020702.
32. Golubchik T, Brueggemann AB, Street T, Gertz RE, Jr.Spencer CCA, Ho T, et al. Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet. 2012; 44: 352–5. doi: 10.1038/ng.107222286217.
33. Aguinagalde L, Corsini B, Domenech A, Domenech M, Cámara J, Ardanuy C, et al. Emergence of amoxicillin-resistant variants of Spain9V-ST156 pneumococci expressing serotype 11A correlates with their ability to evade the host immune response. PLoS One. 2015; 10: e0137565. doi: 10.1371/journal.pone.013756526368279.
34. Akira S, Uematsu S, Takeuchi O, Pathogen recognition and innate immunity. Cell. 2006; 124: 783–801. doi: 10.1016/j.cell.2006.02.01516497588.
35. Kum WWS, Lee S, Grassl GA, Bidshahri R, Hsu K, Ziltener HJ, et al. Lack of functional P-selectin ligand exacerbates Salmonella serovar Typhimurium infection. J Immunol. 2009; 182: 6550–61. doi: 10.4049/jimmunol.080253619414810.
36. Kum WWS, Lo BC, Deng W, Ziltener HJ, Finlay BB, Impaired innate immune response and enhanced pathology during Citrobacter rodentium infection in mice lacking functional P-selectin. Cell Microbiol. 2010; 12: 1250–71. doi: 10.1111/j.1462-5822.2010.01466.x20345490.
37. Osburn WO, Levine JS, Chattergoon MA, Thomas DL, Cox AL, Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection. J Viral Hepat. 2013; 20: 404–13. doi: 10.1111/jvh.1205223647957.
38. Ozment TR, Ha T, Breuel KF, Ford TR, Ferguson DA, Kalbfleisch J, et al. Scavenger receptor class a plays a central role in mediating mortality and the development of the pro-inflammatory phenotype in polymicrobial sepsis. PLoS Pathog. 2012; 8: e1002967. doi: 10.1371/journal.ppat.100296723071440.
39. Yamamoto N, Kawakami K, Kinjo Y, Miyagi K, Kinjo T, Uezu K, et al. Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-γ. Microbes Infect. 2004; 6: 1241–9. doi: 10.1016/j.micinf.2004.08.00715555529.
40. Craig A, Mai J, Cai S, Jeyaseelan S, Neutrophil recruitment to the lungs during bacterial pneumonia. Infect Immun. 2009; 77: 568–75. doi: 10.1128/IAI.00832-0819015252.
41. Surewaard BGJ, Trzciński K, Jacobino SR, Hansen IS, Vughs MM, Sanders EAM, et al. Pneumococcal immune evasion: ZmpC inhibits neutrophil influx. Cell Microbiol. 2013; 15: 1753–65. doi: 10.1111/cmi.1214723601501.
42. Bestebroer J, Poppelier MJJG, Ulfman LH, Lenting PJ, Denis CV, van Kessel KPM, et al. Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood. 2007; 109: 2936–43. doi: 10.1182/blood-2006-06-01546117132726.
43. Doyle NA, Bhagwan SD, Meek BB, Kutkoski GJ, Steeber DA, Tedder TF, et al. Neutrophil margination, sequestration, and emigration in the lungs of L-selectin-deficient mice. J Clin Invest. 1997; 99: 526–33. doi: 10.1172/JCI1191899022088.
44. Matsumoto M, Miyasaka M, Hirata T, P-selectin glycoprotein ligand-1 negatively regulates T-cell immune responses. J Immunol. 2009; 183: 7204–11. doi: 10.4049/jimmunol.090217319890058.
45. Nuñez-Andrade N, Lamana A, Sancho D, Gisbert JP, Gonzalez-Amaro R, Sanchez-Madrid F, et al. P-selectin glycoprotein ligand-1 modulates immune inflammatory responses in the enteric lamina propria. J Pathol. 2011; 224: 212–21. doi: 10.1002/path.285021432853.
46. Domenech M, Araújo-Bazán L, García E, Moscoso M, In vitro biofilm formation by Streptococcus pneumoniae as a predictor of post-vaccination emerging serotypes colonizing the human nasopharynx. Environ Microbiol. 2014; 16: 1193–201. doi: 10.1111/1462-2920.1237024373136.
47. Nieto C, Espinosa M, Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein. Plasmid. 2003; 49: 281–5. 12749839.
48. Ramos-Sevillano E, Moscoso M, García P, García E, Yuste J, Nasopharyngeal colonization and invasive disease are enhanced by the cell wall hydrolases LytB and LytC of Streptococcus pneumoniae. PLoS One. 2011; 6: e23626. doi: 10.1371/journal.pone.002362621886805.
49. Yuste J, Sen A, Truedsson L, Jönsson G, Tay L- S, Hyams C, et al. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect Immun. 2008; 76: 3761–70. doi: 10.1128/IAI.00291-0818541650.
50. Burton RL, Nahm MH, Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin Vaccine Immunol. 2006; 13: 1004–9. doi: 10.1128/CVI.00112-0616960111.
51. de Andrés B, Prado C, Palacios B, Alía M, Jagtap S, Serrano N, et al. Dynamics of the splenic innate-like CD19+CD45Rlo cell population from adult mice in homeostatic and activated conditions. J Immunol. 2012; 189: 2300–8. doi: 10.4049/jimmunol.120022422837485.
52. Sanz JM, Lopez R, Garcia JL, Structural requirements of choline derivatives for ‘conversion’ of pneumococcal amidase. A new single-step procedure for purification of this autolysin. FEBS Lett. 1998; 232: 308–12. doi: 10.1016/0014-5793(88)80759-22897937.
53. de Andrés B, Cortegano I, Serrano N, del Rio B, Martín P, Gonzalo P, et al. A population of CD19highCD45R–/lowCD21low B lymphocytes poised for spontaneous secretion of IgG and IgA antibodies. J Immunol. 2007; 179: 5326–34. 17911619.